ACVR1 inhibitors may hold therapeutic potential as treatment agents targeting the tumor stroma in colorectal cancer; however, BMPs regulate tissue homeostasis by acting on Lgr5+ stem cells in the intestinal epithelium. Here, ACVR1 is linked to neoplasm.